Gerald Ranges

3.2k total citations
37 papers, 2.7k citations indexed

About

Gerald Ranges is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Gerald Ranges has authored 37 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Immunology and Allergy. Recurrent topics in Gerald Ranges's work include Cell Adhesion Molecules Research (10 papers), Immune Response and Inflammation (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Gerald Ranges is often cited by papers focused on Cell Adhesion Molecules Research (10 papers), Immune Response and Inflammation (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Gerald Ranges collaborates with scholars based in United States, France and Germany. Gerald Ranges's co-authors include Terje Espevik, Michael A. Palladino, I S Figari, Sheldon M. Cooper, Sriram Sampath, Lennart D. Johns, Subramaniam Sriram, K C Flanders, Anders Sundan and Mary E. Gerritsen and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Gerald Ranges

37 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald Ranges United States 23 1.4k 785 554 376 337 37 2.7k
T D Geppert United States 24 1.7k 1.2× 1.3k 1.6× 680 1.2× 276 0.7× 133 0.4× 35 3.2k
Druie Cavender United States 30 1.2k 0.8× 744 0.9× 298 0.5× 332 0.9× 208 0.6× 69 3.3k
Thomas E. Eessalu United States 19 1.1k 0.8× 895 1.1× 415 0.7× 207 0.6× 82 0.2× 27 2.3k
Shelby P. Umland United States 28 1.3k 1.0× 709 0.9× 356 0.6× 186 0.5× 171 0.5× 52 2.9k
Eleni Douni Greece 27 1.4k 1.0× 1.2k 1.5× 635 1.1× 177 0.5× 435 1.3× 58 3.2k
Maryrose J. Conklyn United States 19 1.0k 0.7× 718 0.9× 624 1.1× 112 0.3× 160 0.5× 38 2.3k
Gerald M. Feldman United States 27 1.3k 1.0× 1.2k 1.5× 1.2k 2.2× 143 0.4× 112 0.3× 59 2.9k
Jayne Chin United States 20 845 0.6× 1.1k 1.4× 478 0.9× 103 0.3× 164 0.5× 22 2.1k
Koen Vandenbroeck Spain 30 1.2k 0.9× 856 1.1× 462 0.8× 116 0.3× 320 0.9× 96 2.9k
Pércío S. Gulko United States 27 720 0.5× 801 1.0× 471 0.9× 191 0.5× 832 2.5× 78 2.1k

Countries citing papers authored by Gerald Ranges

Since Specialization
Citations

This map shows the geographic impact of Gerald Ranges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Ranges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Ranges more than expected).

Fields of papers citing papers by Gerald Ranges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Ranges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Ranges. The network helps show where Gerald Ranges may publish in the future.

Co-authorship network of co-authors of Gerald Ranges

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Ranges. A scholar is included among the top collaborators of Gerald Ranges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Ranges. Gerald Ranges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schatz, Christoph A., Charlotte Kopitz, Lila Adnane, et al.. (2011). Therapeutic Mechanism and Efficacy of the Antibody–Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9. Molecular Cancer Therapeutics. 11(2). 340–349. 49 indexed citations
2.
Dumas, Jacques, Holia Hatoum‐Mokdad, Robert Sibley, et al.. (2000). 1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(18). 2051–2054. 47 indexed citations
3.
Dumas, Jacques, Robert Sibley, Bernd Riedl, et al.. (2000). Discovery of a new class of p38 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(18). 2047–2050. 34 indexed citations
4.
Gerritsen, Mary E., et al.. (1995). Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression.. Europe PMC (PubMed Central). 147(2). 278–92. 247 indexed citations
5.
Conrad, Patricia J., et al.. (1993). Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. Journal of Leukocyte Biology. 54(5). 399–406. 100 indexed citations
6.
Galloway, Cynthia J., et al.. (1992). Anti‐tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti‐idiotypic antibody. European Journal of Immunology. 22(11). 3045–3048. 7 indexed citations
7.
Johns, Lennart D., K C Flanders, Gerald Ranges, & Subramaniam Sriram. (1991). Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. The Journal of Immunology. 147(6). 1792–1796. 209 indexed citations
8.
Ranges, Gerald, et al.. (1991). A synthetic mycobacterial heat shock peptide prevents adjuvant arthritis but not proteoglycan-induced synovitis in the rat. Inflammation Research. 34(1-2). 148–150. 4 indexed citations
9.
Lowe, David, Wylla M. Nunes, Susan McCabe, et al.. (1989). Genomic Cloning and Heterologous Expression of Human Differentiation-Stimulating Factor. DNA. 8(5). 351–359. 69 indexed citations
10.
Janick‐Buckner, Diane, Gerald Ranges, & Miles P. Hacker. (1989). Alteration of bronchoalveolar lavage cell populations following bleomycin treatment in mice. Toxicology and Applied Pharmacology. 100(3). 465–473. 40 indexed citations
11.
Janick‐Buckner, Diane, Gerald Ranges, & Miles P. Hacker. (1989). Effect of cytotoxic monoclonal antibody depletion of T-lymphocyte subpopulations on bleomycin-induced lung damage in C57BL/6J mice. Toxicology and Applied Pharmacology. 100(3). 474–484. 21 indexed citations
12.
Shalaby, M R, Terje Espevik, Glenn C. Rice, et al.. (1988). The involvement of human tumor necrosis factors- alpha and - beta in the mixed lymphocyte reaction.. The Journal of Immunology. 141(2). 499–503. 97 indexed citations
14.
Cooper, Sheldon M., Sriram Sampath, & Gerald Ranges. (1988). Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma.. The Journal of Immunology. 141(6). 1958–1962. 85 indexed citations
15.
Ranges, Gerald, Albert Zlotnik, Terje Espevik, et al.. (1988). Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines.. The Journal of Experimental Medicine. 167(4). 1472–1478. 147 indexed citations
16.
Ranges, Gerald, et al.. (1988). In Vivo Modulation of Murine Collagen Induced Arthritis. International Reviews of Immunology. 4(1). 83–90. 11 indexed citations
17.
Ranges, Gerald, I S Figari, Terje Espevik, & Michael A. Palladino. (1987). Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.. The Journal of Experimental Medicine. 166(4). 991–998. 422 indexed citations
18.
Ranges, Gerald, Sheldon M. Cooper, & Subramaniam Sriram. (1987). In vivo immunomodulation by monoclonal anti-L3T4. Cellular Immunology. 106(1). 163–173. 18 indexed citations
19.
Ranges, Gerald, Sriram Sampath, & Sheldon M. Cooper. (1985). Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.. The Journal of Experimental Medicine. 162(3). 1105–1110. 315 indexed citations
20.
Ranges, Gerald, et al.. (1982). T cell development in normal and thymopentin-treated nude mice.. The Journal of Experimental Medicine. 156(4). 1057–1064. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026